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Received March 16, 2011; accepted June 21, 2011AbstractBackground: The aim of this study is to investigate which reconstructive route is most appropriate for patients undergoing an esophagectomy for
esophageal cancer.
Methods: Clinical data on 110 patients were retrospectively collected by reviewing their medical charts. In order to evaluate the effects of
adjuvant radiotherapy, patients were interviewed about the adverse side effects they experienced during and after treatment.
Results: The leakage rate was significantly lower in group that received posterior mediastinal reconstruction compared with the group that
received retrosternal reconstruction (7.1% vs. 39%, p¼ 0.01). There were no significant differences between groups in terms of side effects
related to adjuvant chemoradiotherapy or radiotherapy. The quality-of-life reports of patients who received adjuvant radiotherapy were not
significantly different between the two study groups.
Conclusion: For patients with esophageal cancer who undergo an esophagectomy followed by gastric conduit reconstruction, the posterior
mediastinal route is superior to the retrosternal route in regard to anastomotic leakage and hospital mortality. Adjuvant radiotherapy did not
influence the postoperative functions of the gastric conduit used for reconstruction in either route.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Esophageal carcinoma is an aggressive malignancy with
a poor clinical prognosis. Although there are an increasing
number of therapeutic options that can be used to treat esopha-
geal cancer, surgical resection remains the mainstay of treat-
ment. Esophageal resection for esophageal cancer is usually
performed in two steps: cancer resection followed by recon-
struction in order to allow the patient to eat food normally. The
stomach is themost commonly used substitute for reconstruction* Corresponding author. Dr. Han-Shui Hsu, Division of Thoracic Surgery,
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doi:10.1016/j.jcma.2011.09.006after esophagectomy.1e3 Usually, there are multiple options for
the placement of the gastric conduit: the retrosternal, posterior
mediastinal, subcutaneous, right intrathoracic, and left intra-
thoracic routes are often used.4Among these, the retrosternal and
posterior mediastinal route are the most commonly used for
reconstruction after esophagectomy.5e7 Some studies have re-
ported the advantages and disadvantages of these reconstructive
routes after esophageal resection. The posterior mediastinal
route has lower reported rates of morbidity and mortality after
surgery.8,9 For esophageal carcinoma, complete eradication of
the disease by esophageal resection and lymph node dissection
can only be achieved in a small proportion of patients. Great
interest has been directed toward the use of multimodalities,
including adjuvant chemoirradiation, to better treat this disease.
The use of chemoradiotherapy after radical resection has beenhinese Medical Association. All rights reserved.
Table 1
Clinical data on 110 patients who underwent esophagectomy at Taipei
Veterans General Hospital, 2006e2008.
Variables No. (%)
Number of patients 110
Age (years, mean) 38e89 (61.3 12.3)
Gender
Male 100 (90.9)
Female 10 (9.1)
Reconstructive route
Retrosternal 82 (74.5)
Posterior mediastinal 28 (25.5)
Leakage
Yes 34 (30.9)
No 76 (69.1)
Pathological stage
Stage I 19 (17.3)
Stage II 35 (31.8)
Stage III 42 (38.2)
Stage IV 14 (12.7)
Adjuvant radiotherapy
Retrosternal 42 (38.1)
Posterior mediastinal 12 (10.9)
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disease.10e14 However, the side effects of radiotherapy on the
bypass conduit are a great concern for patientswhomust undergo
reconstruction via the posterior mediastinal route. Few studies
have been reported in the literature that investigated the effects of
postoperative radiation on the gastric conduit and how this
impedes swallowing functions in patients after reconstruction.
The aim of this study is to evaluate postoperative morbidities,
including the anastomotic leakage rate and other side effects
caused by adjuvant radiotherapy, in patients who undergo
esophageactomy for esophageal cancer followed by recon-
structionvia either the retrosternal or posteriormediastinal route.
2. Methods
From January 2006 to December 2008, esophagectomies for
esophageal cancer were performed in 113 patients at Taipei
Veterans General Hospital. Among these patients, three patients
who had reconstruction with a segment from the colon were
excluded from this study. All patients had a complete preoper-
ative check-up that included an esophagogastroscopy, computed
tomography (CT) of the chest and upper abdomen, pulmonary
function tests, and, in those suspected of having metastatic
cancer, a whole-body positron emission tomography (PET) scan.
The approaches for performing an esophagectomy include right
transthoracic, video-assisted thoracoscopic surgery (VATS) and
transhiatal and left-side thoracoabdominal approaches; the
decision regarding which approach is most appropriate depends
on the location of tumor, the depth of the tumor invasion, and the
surgeon’s preference. For patients who underwent the trans-
thoracic approach (open thoracotomy or VATS), the retrosternal
route was routinely used for reconstruction unless short gastric
tubes were noted during the operation. For patients who under-
went the transhiatal or thoracoabdominal approach, the posterior
mediastinal route was used for reconstruction. To restore the
continuity of the gastrointestinal tract after an esophagectomy,
the stomach was used as the conduit for reconstruction in all
patients enrolled in this study. The gastric conduit is made by
immobilizing the stomach and forming a gastric tube by resec-
tion stapling of the lesser curvature, during which the left gas-
troepiploic artery, left gastric arteries, and short gastric artery are
subsequently ligated and divided and the branches of the right
gastroepiploic artery and right gastric artery are preserved. The
gastric conduit is then pulled up to the neck through either the
retrosternal or posterior mediastinal route. In patients who
underwent the transhiatal approach or left-side thor-
acoabdominal approach for esphagectomy, reconstruction
through the posterior mediastinal route was performed. Anas-
tomosis was conducted in the neck of each patient using the
hand-sewing technique. A jejunostomy feeding tube was
routinely used at the end of the operation.Clinical data, including
postoperative complications (anastomotic leakage, prolonged
ventilation, pneumonia, chylothorax, postoperative bleeding,
myocardial infarction, etc.), intra-operative blood loss, operation
time, time spent in the ICU, time required before extubation after
surgery, and mortality were retrospectively collected by
reviewing the medical charts of each patient. Patients wereweaned off their ventilators when theymet the necessary criteria,
and they were transferred back to the ward the next day. The
definition of anastomotic leakage was the evacuation of saliva
from neck wound, and prolonged ventilation was defined as the
need for mechanical ventilation for more than 7 days in the ICU.
Patients with lymph node metastasis received adjuvant chemo-
irradiation. The chemoirradiation protocols and dosages were
similar in all patients, including the administration of radiation
dosages up to 5000 cGy and cisplatin-based chemotherapy.
Contrast- or transit-time studies, in order to evaluate the func-
tions of the gastric tube, were not routinely performed during the
postoperative period. To evaluate the effect of adjuvant radio-
therapy on the conduit during the postoperative period, the
patients were interviewed and asked questions regarding the
adverse effects of radiation during treatment. The questionnaire
used was modified from that used by Aaronson et al.15 Statistical
differences between these two groups were determined using the
c2, Fisher’s exact, or independent t test; p< 0.05was considered
significant.
3. Results
The clinical data on the 110 patients who underwent an
esophagectomy and reconstruction for esophageal squamous
cell carcinoma (ESCC) are shown in Table 1. The pathological
diagnoses of the 110 patients included squamous cell carcinoma
(103 patients), adenocarcinoma (1 patient),malignantmelanoma
(1 patient), spindle cell carcinoma (1 patient), carcinosarcoma (2
patients), adenosquamous carcinoma (1 patient), and mucoepi-
dermoid carcinoma (1 patient). There were 100 male and 10
female patients enrolled in this study. Their ages ranged from 38
years to 89 years, with a mean age of 61 years. Eighty-two
patients underwent reconstruction via the retrosternal route
Table 3
Comparison of postoperativemorbidity andmortality in patients who underwent
retrosternal or posterior mediastinal reconstruction after esophagectomy.
Retrosternal
(n¼ 82)
Post. Mediastinal
(n¼ 28)
p
Operative times (minutes) 528.6 439.2 0.001*
Blood loss (mL) 556.6 488.9 0.379
Major complication (%)
Anastomotic leakage 32 (39.0) 2 (7.1) 0.001*
Prolonged mechanical
ventilation
12 (14.6) 2 (7.14) 0.250
(>7 d) 2 (2.4) 1 (3.5) 0.590
Pneumonia 3 (3.6) 1 (3.5) 0.732
Chylothorax 2 (2.4) 0 d
Postoperative bleeding 1 (1.2) 0 d
Myocardial infarction 4 (4.8) 1(3.5) 0.021*
Hospital mortality
ICU stay (d) 8.5 7.1 0.390
Hospital stay (d) 25.5 23.6 0.518
Time to extubation (d) 4.7 3.7 0.048*
*p< 0.05.
Table 4
Side effects encountered during treatment of patients who received concurrent
adjuvant chemoradiotherapy.
Retrosternal
(n¼ 21)
Post. mediastinal
(n¼ 8)
p
Hematemesis
Yes 0 1 0.276
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(PM group). Most of the tumors were located in the middle to
lower third of the esophagus. Anastomotic leakage was noted in
34 patients (30.9%). Fifty-four patients, including 42 patients in
the RS group and 12 patients in the PM group, received adjuvant
radiotherapy. Table 2 shows the results of comparisons between
the RS and PM groups. Patients who underwent the posterior
mediastinal route were older than patients who underwent the
retrosternal route ( p¼ 0.007). There were no significant differ-
ences in terms of the tumor location or stage between these two
groups. In the PM group, most of the patients underwent the left-
side thoracoabdominal or transhiatal approach for esoph-
agectomy ( p< 0.001). The leakage rate was significantly lower
in the PM group than in the RS group (7.1% vs. 39%, p¼ 0.01).
In addition to a higher incidence of leakage, the RS group
required a longer operative time and time to extubate and had
a higher mortality rate compared to the PM group (Table 3).
There were two patients in the RS group who suffered from
postoperative bleeding that required an additional operation.One
patient was found to have bleeding due to the thoracotomy, and
the other patient had bleeding in the retrosternal tunnel. Tables 4
and 5 show the results of the interviews and the questions that
were asked regarding quality of life following adjuvant radio-
therapy. Therewere no significant differences between groups in
terms of side effects caused by concurrent adjuvant chemo-
radiotherapy or radiotherapy. All patients in both groups who
received adjuvant chemoradiotherapy were able to finish the
entire course of treatment. Quality-of life-reports after adjuvantTable 2
Comparison of patients who underwent reconstruction via the retrosternal or
posterior mediastinal route after esophagectomy.
Retrosternal Post. mediastinal p
Number of patients 82 28 d
Mean age (years) 59.5 11.4 66.7 13.5 0.007*
Male/Female 75/7 25/3 0.492
Tumor location
Upper third 5 2 0.069
Middle third 49 10
Lower third 28 16
Pathological stage
Stage I 11 8 0.233
Stage II 28 7
Stage III 31 11
Stage IV 12 2
Approaches for esophagectomy
Right thoracotomy
or VATS
81 10 <0.001*
Left thoracoabdominal
or transhiatal
1 18
Adjuvant chemoradiotherapy
Yes 42 12 0.514
No 40 16
Anastomotic leakage
Yes 32 (39%) 2 (7.1%) 0.001*
No 50 (61%) 26 (92.9%)
*p< 0.05.
No 21 7
Chest pain or tightness
Yes 4 2 0.543
No 17 6
Vomiting/nausea
Yes 2 1 0.636
No 19 7
Poor appetite
Yes 12 2 0.129
No 9 6
Weakness
Yes 16 1 0.003
No 5 7
Dyspnea
Yes 4 1 0.575
No 17 7
Difficulty swallowing
Yes 12 3 0.298
No 9 5
Sleep problems
Yes 9 2 0.330
No 12 6
Constipation
Yes 3 0 0.364
No 18 8
Diarrhea
Yes 3 0 0.364
No 18 8
Treatment completed (%) 100% 100% d
Table 5
Evaluation of quality-of-life reports completed by patients who underwent
esophagectomy followed by adjuvant concurrent chemoradiotherapy.
Retrosternal (n¼ 21) Post. mediastinal
(n¼ 8)
p
What kinds of the food can you eat?
Solid 15 6 0.618
Soft 6 2
Liquid 0 0
Do you suffer from regurgitation?
Yes 14 6 0.517
No 7 2
Did you receive esophageal dilatation?
Yes 12 3 0.298
No 9 5
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groups.
4. Discussion
For patients who require an esophagectomy for esophageal
cancer, the route for reconstruction is often debated. Some
surgeons recommend the retrosternal route because it offers
some advantages. The use of this route can avoid the effects of
irradiation to the conduit during adjuvant radiotherapy.6 Van
Lanschot and colleagues concluded that in patients at high risk
of developing secondary malignant dysphagia, the extra-
anatomical route is the best choice.7 Wong and associates re-
ported that recurrent tumor infiltration of the gastric conduit
occurs in 14% of patients when the orthotopic route is used.16
Katsoulis et al reported that retrosternal interposition can mini-
mize reflux compared with the use of the posterior mediastinal
route. Reflux of the contents of the duodenum following poste-
rior mediastinal reconstruction is less severe.17 In addition, the
retrosternal route has been advocated as a way to decrease the
risk of postoperative pneumonia because distention of the
stomach with air and/or fluid in the early postoperative period
does not compress the lungs.18 In contrast, some authors advo-
cate the use of the posteriormediastinal route because it is shorter
and results in fewer cardiopulmonary complications and anas-
tomotic leaks, which may be related to its lower rates of hospital
mortality.4,5,19,20 A meta-analysis of six randomized controlled
trials by Urschel and colleagues, however, reported that the
posterior and anterior mediastinal routes are associated with
similar outcomes after esophagectomy for cancer.21 In our study,
103 of 110 patients with esophageal cancer were diagnosed with
squamous cell carcinoma.Most of these patients received a right
thoracotomy for esophagectomy with reconstruction via the
retrosternal route. When the tumor was located in the lower third
of the esophagus or if the patient had poor cardiopulmonary
functions, the left thoracoabdominal or transhiatal approach was
performed with reconstruction via the posterior mediastinal
route. The data from our retrospective review shows that the rate
of anastomotic leakage was significantly higher in patients who
underwent the retrosternal route compared with those whounderwent the posterior mediastinal route. A higher operative
mortality was also noted in the group of patients that underwent
the retrosternal route. Some authors have also demonstrated
a significantly higher rate of leakage following reconstructionvia
the retrosternal route.3,20 In addition to anastomotic leakage,
bleeding has been reported as a uncommon side effect when
creating the substernal tunnel.1 In our study, one patient expe-
rienced postoperative bleeding in the retrosternal tunnel, which
necessitated an additional operation. In addition, the patients in
the PM group were older than the patients in the RS group in this
study. This may be because some of the patients who underwent
posterior mediastinal reconstruction had undergone a transhiatal
esophagectomy, and these patients are likely to be older and have
poorer pulmonary functions.
The incidence of anastomotic leakage in patients who
underwent reconstruction via the retrosternal route after esoh-
pagectomy has been reported to range from 2.1% to 70%.15,20,22
It has been reported that nearly 50% of cervical anastomotic
leaks result from anastomotic strictures and the subsequent need
for chronic dilatations, which negate the merits of an operation
intended to restore comfortable swallowing.23 Some authors
have suggested that the increased risk of anastomotic leakage in
patients who undergo retrosternal reconstruction is due to the
additional length of reconstruction that is required if anasto-
mosis is made over the neck and the tight angulation of the
thoracic inlet.1,4 In order to facilitate exposure and to avoid
compression of the gastric tubewhen it is brought up to the neck
during retrosternal reconstruction, some author favor removal
of a portion of the manubrium, associated costal cartilage, and
themedial portion of the left clavicle.1,4 In this study,most of the
tumors were located in the middle third of the esophagus. To
obtain better clinical results, anastomosis after esophageactomy
was carried out at the neck without removal of the manubrium.
Blunt dissection was performed in order to enlarge the thoracic
inlet as much as possible and avoid compression of the gastric
conduit; however, leakage was still noted in up to 39% of
patients who underwent the retrosternal route. Regarding
whether a different approach would affect the leakage rate, 91
patients of 110 patients in this study underwent the transthoracic
approach for esophagectomy (including right-side thoracotomy
and VATS). Eighty-four patients underwent right-side thora-
cotomy and only seven patients underwent a minimally invasive
procedure for esophagectomy. It has been reported that there are
no significant differences in terms of postoperative outcomes,
including the leakage rate and hospital mortality, between
patients who undergo open thoracotomy andminimally invasive
procedures.24e26 In this study, the leakage rates of these two
groups of patients were not different.
Another concern regarding which route patients should
undergo for reconstruction is the possible effects of adjuvant
chemoirradiation. Few studies in the literature have discussed
whether the effects of radiation would influence the functions of
the gastric substitute. Gawad and associates recommend the
posteriormediastinal route, but suggest that curative resection be
mandatory in order to avoid possible complications due to local
recurrence. After incomplete resection, retrosternal reconstruc-
tion is recommended for better palliation.9 Kunisaki and
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be considered as the adopted method of choice after palliative
esophagectomy because of the need for further radiotherapy.27
However, even with complete resection, tumor recurrence after
esophagectomy for esophageal cancer is common, which further
necessitates the need for adjuvant therapy to decrease the like-
lihood of local recurrence.10,13,28 In this study, in order to eval-
uate the radiation-induced adverse side effects, we interviewed
the patients who underwent either retrosternal or posterior
mediastinal reconstruction about swallowing functions in the
postoperative period. We found that there were no significant
differences between the two groups in terms of radiotherapy-
related adverse effects, quality of life after radiotherapy, or the
need for further esophageal dilatation. The reason that more
patients in the RS group felt weakness may be because these
patients had poor appetites and swallowing difficulties, although
these findings were not statistically significant. Most impor-
tantly, all of these patients could tolerate and complete the whole
course of adjuvant radiotherapy.
There are some limitations to this study. Because this study
is retrospective, we are not able to thoroughly evaluate swal-
lowing functions in all patients who underwent an esoph-
agectomy for esophageal cancer. Also, only patients who
underwent esophagectomies in the past 3 years were enrolled
in the study; therefore, it was difficult to investigate the rela-
tionship between tumor recurrence and secondary dysphagia
that patients might encounter in the follow-up period. Future
studies with a larger patient cohort and longer follow-up
period may be needed to elucidate the effects of adjuvant
radiation on the gastric substitute and quality of life in patients
who undergo an esophagectomy.
In conclusion, for patients with esophageal cancer who
require an esophagectomy followed by gastric conduit
reconstruction, the posterior mediastinal route is superior to
the retrosternal route in regard to anastomotic leakage and
hospital mortality. Adjuvant radiotherapy did not influence the
postoperative functions of the gastric conduit used in either
reconstructive route. We suggest that for patients who have
undergone curative resection for esophageal cancer, recon-
struction with a gastric tube via the posterior mediastinal route
should be considered.Acknowledgments
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